Home
Scholarly Works
US Medicare reform: why drug companies and private...
Journal article
US Medicare reform: why drug companies and private insurers are smiling.
Authors
Hurley J; Morgan S
Journal
Canadian Medical Association Journal, Vol. 170, No. 4, pp. 461–462
Publication Date
February 17, 2004
ISSN
0820-3946
Associated Experts
Jeremiah Hurley
Dean, Faculty of Social Sciences
Visit profile
Labels
Fields of Research (FoR)
32 Biomedical and clinical sciences
42 Health sciences
Medical Subject Headings (MeSH)
Health Care Reform
Humans
Insurance, Health
Legislation, Drug
Medicare
Pharmaceutical Preparations
United States
Contact the Experts team
Get technical help
or
Provide website feedback